Page 2 - Aster Dm Healthcare

Olympus Capital divests 9.8% stake in Aster DM Healthcare for Rs 1,978 cr

Private equity firm Olympus Capital Asia on Wednesday divested a 9.8 per cent stake in Aster DM Healthcare for Rs 1,978 crore through open market transactions. Olympus Capital Asia through its two affiliates -- Olympus Capital Asia Investments Ltd and Olympus ACF Pte -- offloaded the shares of Dubai-based Aster DM Healthcare on the bourse. According to the bulk deal data available with the BSE, more than 4.42 crore equity shares of Aster DM Healthcare were sold by Olympus Capital Asia Investments and 45.59 lakh shares by Olympus ACF Pte Ltd of the company. Around 4.88 crore shares sold represent a 9.8 per cent stake in Aster DM Healthcare. The shares were disposed of within the price range of Rs 405-406.72 apiece, taking the transaction value to Rs 1,978.35 crore. As of December 2023, Olympus Capital Asia Investments Ltd owned an 18.96 per cent stake in Aster DM Healthcare, shareholding data showed with the bourse. Meanwhile, Capital Group through its affiliate SmallCap World Fun

Aster DM, CDSL dip up to 7% after 10% equity changes hands via block deals

Aster DM sees nearly 10 per cent of its equity change hands, while 10.23 per cent equity of CDSL were traded in a black deal on Wednesday.

Stocks to watch on March 27: Aster DM, Adani Ports, CDSL, SpiceJet, L&T

Stocks to watch on March 27: SpiceJet on Tuesday said it had signed an agreement with aircraft lessor Export Development Canada (EDC) to settle liabilities worth Rs 755 crore

PE firm Olympus to sell 9.8% stake in India's Aster DM for up to $234.5 mn

Olympus Capital, which owns about 19% stake in the hospital chain, is planning the sale at 400-437.20 rupees per share

Aster DM's deal to separate India and GCC businesses nears completion

In November 2023, Aster DM had received corporate approvals to separate its India and Gulf Cooperation Council (GCC) businesses into two distinct and standalone entities

Aster DM Healthcare Q3 results: Profit rises 28.6% to Rs 179 crore

Consolidated net profit for the third quarter rose 28.6% to Rs 179 cr ($21.6 million), the company said on Thursday

Aster DM shareholders approve separation of firm's India, GCC businesses

Aster DM earlier announced plans to separate its India and Gulf businesses in a deal valued at $1 billion

Aster DM Healthcare shareholders approve proposal to hive off Gulf biz

Hospital chain Aster DM Healthcare on Tuesday said its shareholders have approved the proposal to hive off its Gulf business in a deal valued at USD 1.01 billion. The proposed resolutions were passed with the requisite majority by shareholders on January 22, the company said in a regulatory filing. Over 99 per cent of the votes polled were in favour of the deal, it added. On November 28 last year, Aster DM Healthcare announced that it would separate its India and Gulf businesses by way of a deal worth over USD 1 billion. The company stated that it has received approval from its board and subsidiary Affinity Holdings Pvt Ltd to separate the India and GCC businesses into two distinct and standalone entities. Under the separation plan, Affinity entered into a definitive agreement with a consortium of investors led by Fajr Capital, a private equity firm headquartered in the UAE, to invest in Aster's GCC business. Upon completion, the separation of the India and GCC businesses will ..

Aster DM to pay up to Rs 120 a share dividend on Gulf business sale

In November, Aster DM had announced its plans to sell its wholly-owned subsidiary Affinity Holdings, which conducts business in the Gulf Cooperation Council (GCC) region, to Alpha GCC for $1 billion

Voting advisory firm opposes Aster DM Healthcare's sale of Gulf business

IiAS raises concern over lack of clarity on the utilisation of sale proceeds of unit that contributes 75% of revenue

Investor perception about Aster DM Healthcare is 'very upbeat': CEO

Group will avoid being 'one of those players' with a token presence through a single hospital, says Nitish Shetty

As Covid-19 cases rise in India; should you keep pharma stocks on radar?

Barring Dr Lal Pathlabs, the other four healthcare related stocks listed below seem to be trapped in a range for now, charts suggest.

Hospital and pharmacy chain Aster to fuel India expansion through buyouts

Aster plans to add an additional 1,500 beds to the current 4,800 capacity in the world's most populous country over the next three years and "look at companies that are not listed

Margin gains likely to further boost Aster DM Healthcare stock price

The company had been keen to sell the stake in the GCC business for some time now given a hypercompetitive environment, lower growth (a third of the India business) and lower margins

Aster DM Healthcare soars 15%; hits new high on stake sale plan in Gulf biz

The company announced on Tuesday that its subsidiary would sell its stake in Aster DM Healthcare FZC to Alpha GCC for $1.01 billion (Rs 8,125 crore).

Stocks to Watch today: IREDA, Zomato, Siemens, PCBL, Aster DM, IOC, IT

Stocks to watch on Wednesday, November 29, 2023: IREDA is likely to debut on a strong note on the bourses today following the robust response received to its recently concluded IPO.

Aster DM Healthcare sells stake in Gulf business for $1.01 billion

Aster to separate its India and GCC businesses to unlock value

Aster DM Healthcare Q2 results: Consolidated revenue rises 17.7%

On a sequential basis, the company exhibited a 3.15 per cent increase in revenue along with EBITDA, which grew 21 per cent year-on-year

Aster DM Healthcare's India unit draws suitors valuing business at $1.5 bn

Aster shares have soared about 40% this year, valuing the Mumbai-listed company at about $1.9 billion

Aster DM posts 93% fall in Q1 profit on new hospital losses, taxes

Aster DM's new hospitals, including Aster Royal Hospital Muscat and Aster Narayanadri Tirupati, reported losses of Rs 2900 cr for the June quarter, the company said